{"id":"W4401413268","doi":"10.1182/blood.2024025802","title":"Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital; Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Cancer Institute; Genentech; National Institutes of Health; AOP Orphan; Swedish Orphan Biovitrum; Servier; Astellas Pharma; Galecto; Sierra Oncology; Incyte; CTI Biopharma; Astex Pharmaceuticals; Jazz Pharmaceuticals; Celgene; Amgen; Ariad Pharmaceuticals; Gilead Sciences; Bristol-Myers Squibb; American Society of Clinical Oncology; Pfizer; Constellation Pharmaceuticals; Agios Pharmaceuticals","keywords":"Medicine; Myelofibrosis; Anemia; Internal medicine; Bone marrow","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1071042,0.001833812,0.002841091,0.007021058,0.002236894,0.008820188,0.007743229,0.01207669,0.006782499],"category_scores_gemma":[0.1862777,0.001443132,0.00670676,0.004059544,0.004908361,0.004339575,0.00557448,0.01953858,0.008558129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009059938,"about_ca_system_score_gemma":0.02122794,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009751112,"about_ca_topic_score_gemma":0.008964346,"domain_scores_codex":[0.9129218,0.03048628,0.02923349,0.003380489,0.01956179,0.004416157],"domain_scores_gemma":[0.7677636,0.06433511,0.01817116,0.008557452,0.1363393,0.004833381],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0003257172,0.0002173261,0.002958913,0.002295628,0.00009776348,0.0005999086,0.001406586,0.001103171,0.001272921,0.03157387,0.8672276,0.09092057],"study_design_scores_gemma":[0.0002748402,0.0002801383,0.006772485,0.00476027,0.0001909401,0.0008380135,0.0006843024,0.001032785,0.001621892,0.01164828,0.9717398,0.0001562709],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"methods","genre_scores_codex":[0.01036706,0.02539861,0.1178837,0.5644265,0.1572185,0.0179125,0.01528961,0.002322255,0.08918118],"genre_scores_gemma":[0.05184811,0.01613971,0.4559548,0.2680853,0.04605369,0.02787521,0.03848239,0.00182881,0.09373192],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.1071042,"threshold_uncertainty_score":0.5664282,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0340283563664436,"score_gpt":0.3251509218668734,"score_spread":0.2911225655004298,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}